Overview
KMTS market data
Price History
KMTS price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.30 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.51 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $13.25 – $30.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $1.4K · P/B 6.01 · P/S 17.26.
Company news
Oppenheimer Initiates Coverage On Kestra Medical Techs with Perform RatingBenzinga · Jul 21, 2026, 12:23 PM
BTIG Maintains Buy on Kestra Medical Techs, Raises Price Target to $32Benzinga · Jul 15, 2026, 11:08 AM
8-K filing — KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)SEC EDGAR · Jul 14, 2026, 8:08 PM
Kestra Medical Technologies Signs Five-Year, $200M Term Loan FinancingBenzinga · Jul 14, 2026, 8:07 PM
Kestra Medical Techs Sees FY2027 Sales $137.000M vs $132.895M EstBenzinga · Jul 14, 2026, 8:06 PM
Kestra Medical Techs Q4 EPS $(0.67) Misses $(0.59) Estimate, Sales $28.638M Beat $26.479M EstimateBenzinga · Jul 14, 2026, 8:04 PM
Earnings Scheduled For July 14, 2026Benzinga · Jul 14, 2026, 11:11 AM